መነሻME • NASDAQ
add
23andMe Holding Co.
የቀዳሚ መዝጊያ
$4.91
የቀን ክልል
$4.88 - $5.05
የዓመት ክልል
$4.80 - $20.20
የገበያው አጠቃላይ ዋጋ
118.32 ሚ USD
አማካይ መጠን
224.52 ሺ
የዋጋ/ገቢ ምጥጥን
-
የትርፍ ክፍያ
-
ዋና ልውውጥ
NASDAQ
ዜና ላይ
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
(USD) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ገቢ | 40.41 ሚ | -33.60% |
የሥራ ወጪ | 92.47 ሚ | -31.87% |
የተጣራ ገቢ | -69.40 ሚ | 33.67% |
የተጣራ የትርፍ ክልል | -171.72 | 0.10% |
ገቢ በሼር | -2.42 | 44.16% |
EBITDA | -67.97 ሚ | 30.77% |
ውጤታማ የግብር ተመን | — | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
(USD) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 169.97 ሚ | -45.93% |
አጠቃላይ ንብረቶች | 368.05 ሚ | -57.75% |
አጠቃላይ ተጠያቂነቶች | 224.54 ሚ | 14.73% |
አጠቃላይ እሴት | 143.50 ሚ | — |
የሼሮቹ ብዛት | 25.30 ሚ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 0.87 | — |
የእሴቶች ተመላሽ | -47.14% | — |
የካፒታል ተመላሽ | -74.53% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
(USD) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
የተጣራ ገቢ | -69.40 ሚ | 33.67% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | -43.27 ሚ | 37.61% |
ገንዘብ ከኢንቨስትመንት | -1.16 ሚ | 57.11% |
ገንዘብ ከፋይናንስ | 9.00 ሺ | 107.89% |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | -44.42 ሚ | 38.73% |
ነፃ የገንዘብ ፍሰት | -17.86 ሚ | 62.57% |
ስለ
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
ኤፕሪ 2006
ዋና መሥሪያ ቤት
ድህረገፅ
ሠራተኞች
571